Asset Details
Do you wish to reserve the book?
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer
Do you wish to request the book?
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer
2011
Overview
Pioneering work in the 1990s first linked a novel microaerobic bacterium, Helicobacter hepaticus, with chronic active hepatitis and inflammatory bowel disease in several murine models. Targeted H. hepaticus infection experiments subsequently demonstrated its ability to induce colitis, colorectal cancer, and extraintestinal diseases in a number of mouse strains with defects in immune function and/or regulation. H. hepaticus is now widely utilized as a model system to dissect how intestinal microbiota interact with the host to produce both inflammatory and tolerogenic responses. This model has been used to make important advances in understanding factors that regulate both acquired and innate immune response within the intestine. Further, it has been an effective tool to help define the function of regulatory T cells, including their ability to directly inhibit the innate inflammatory response to gut microbiota. The complete genomic sequence of H. hepaticus has advanced the identification of several virulence factors and aided in the elucidation of H. hepaticus pathogenesis. Delineating targets of H. hepaticus virulence factors could facilitate novel approaches to treating microbially induced lower bowel inflammatory diseases.
Publisher
Elsevier Inc,Nature Publishing Group US,Elsevier Limited
Subject
/ Animals
/ Biomedical and Life Sciences
/ Colorectal Neoplasms - microbiology
/ Colorectal Neoplasms - pathology
/ Helicobacter hepaticus - genetics
/ Helicobacter hepaticus - immunology
/ Helicobacter hepaticus - pathogenicity
/ Helicobacter Infections - immunology
/ Helicobacter Infections - microbiology
/ Helicobacter Infections - pathology
/ Inflammatory Bowel Diseases - immunology
/ Inflammatory Bowel Diseases - microbiology
/ Inflammatory Bowel Diseases - pathology
/ Lower Gastrointestinal Tract - immunology
/ Lower Gastrointestinal Tract - microbiology
/ Lower Gastrointestinal Tract - pathology
/ Mice
/ review
